Farther Finance Advisors’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $51.5K | Buy |
1,428
+760
| +114% | +$27.4K | ﹤0.01% | 2115 |
|
|
2025
Q1 | $20.8K | Buy |
668
+31
| +5% | +$967 | ﹤0.01% | 2367 |
|
|
2024
Q4 | $16.3K | Buy |
637
+222
| +53% | +$5.67K | ﹤0.01% | 2171 |
|
|
2024
Q3 | $11.8K | Sell |
415
-30
| -7% | -$849 | ﹤0.01% | 2302 |
|
|
2024
Q2 | $11.7K | Sell |
445
-40
| -8% | -$1.05K | ﹤0.01% | 2018 |
|
|
2024
Q1 | $14.5K | Sell |
485
-39
| -7% | -$1.17K | ﹤0.01% | 1605 |
|
|
2023
Q4 | $14.7K | Buy |
524
+497
| +1,841% | +$14K | ﹤0.01% | 1441 |
|
|
2023
Q3 | $733 | Buy |
27
+14
| +108% | +$380 | ﹤0.01% | 2163 |
|
|
2023
Q2 | $400 | Sell |
13
-25
| -66% | -$769 | ﹤0.01% | 2215 |
|
|
2023
Q1 | $1.37K | Buy |
38
+33
| +660% | +$1.19K | ﹤0.01% | 1764 |
|
|
2022
Q4 | $198 | Buy |
+5
| New | +$198 | ﹤0.01% | 2041 |
|